Graphic Online
BY: Doreen Andoh
705
The World is marking International Childhood Cancer Day (ICCD) today, February 15, and to emphasise the importance of the day, the World Health Organisation (WHO) says Cancers in Children is the leading cause of death among children between zero and 19 years, with 300,000 new cases expected to be diagnosed each year globally.
Landmark
On the landmark 20th edition of the International Childhood Cancer Awareness Day, Childhood Cancer International (CCI) and the International Society of Pediatric Oncology (SIOP) have unveiedl a joint three-year campaign, ‘Tree of Life’ concept and Advocacy Toolkit to amplify the message of hope and accelerate life-saving progress for young cancer patients worldwide.
Study characterizes cisplatin-induced hearing loss in pediatric cancer patients
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases. Permanent hearing loss is a common side effect of this medication, but until now, studies have been too small and too varied to accurately characterize this risk.
Today in
The Lancet Child & Adolescent Health, investigators at Children s Hospital Los Angeles published results of the largest study of cisplatin-induced hearing loss to date. The study establishes the first benchmarks for the prevalence of hearing loss, and reveals that the risk of hearing loss is affected not only by how much drug is given, but by how that drug is delivered dosing schedules, complementary treatments, and more.